These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17901130)

  • 1. Phosphorylation of steroidogenic factor 1 is mediated by cyclin-dependent kinase 7.
    Lewis AE; Rusten M; Hoivik EA; Vikse EL; Hansson ML; Wallberg AE; Bakke M
    Mol Endocrinol; 2008 Jan; 22(1):91-104. PubMed ID: 17901130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella-zoster virus IE63 protein phosphorylation by roscovitine-sensitive cyclin-dependent kinases modulates its cellular localization and activity.
    Habran L; Bontems S; Di Valentin E; Sadzot-Delvaux C; Piette J
    J Biol Chem; 2005 Aug; 280(32):29135-43. PubMed ID: 15955820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA polymerase II C-terminal heptarepeat domain Ser-7 phosphorylation is established in a mediator-dependent fashion.
    Boeing S; Rigault C; Heidemann M; Eick D; Meisterernst M
    J Biol Chem; 2010 Jan; 285(1):188-96. PubMed ID: 19901026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7.
    Rochette-Egly C; Adam S; Rossignol M; Egly JM; Chambon P
    Cell; 1997 Jul; 90(1):97-107. PubMed ID: 9230306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase.
    Ye M; Duus KM; Peng J; Price DH; Grose C
    J Virol; 1999 Feb; 73(2):1320-30. PubMed ID: 9882337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation.
    Bockstaele L; Bisteau X; Paternot S; Roger PP
    Mol Cell Biol; 2009 Aug; 29(15):4188-200. PubMed ID: 19487459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of Cdk7 activation by dual T-loop phosphorylation.
    Düster R; Anand K; Binder SC; Schmitz M; Gatterdam K; Fisher RP; Geyer M
    Nat Commun; 2024 Aug; 15(1):6597. PubMed ID: 39097586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mat1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipocyte differentiation.
    Helenius K; Yang Y; Alasaari J; Mäkelä TP
    Mol Cell Biol; 2009 Jan; 29(2):315-23. PubMed ID: 18981214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular mechanism of mitotic inhibition of TFIIH is mediated by phosphorylation of CDK7.
    Akoulitchev S; Reinberg D
    Genes Dev; 1998 Nov; 12(22):3541-50. PubMed ID: 9832506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylation.
    Yang WH; Heaton JH; Brevig H; Mukherjee S; Iñiguez-Lluhí JA; Hammer GD
    Mol Cell Biol; 2009 Feb; 29(3):613-25. PubMed ID: 19015234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corepressor MMTR/DMAP1 is involved in both histone deacetylase 1- and TFIIH-mediated transcriptional repression.
    Kang BG; Shin JH; Yi JK; Kang HC; Lee JJ; Heo HS; Chae JH; Shin I; Kim CG
    Mol Cell Biol; 2007 May; 27(10):3578-88. PubMed ID: 17371848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human TFIIH Kinase CDK7 Regulates Transcription-Associated Chromatin Modifications.
    Ebmeier CC; Erickson B; Allen BL; Allen MA; Kim H; Fong N; Jacobsen JR; Liang K; Shilatifard A; Dowell RD; Old WM; Bentley DL; Taatjes DJ
    Cell Rep; 2017 Aug; 20(5):1173-1186. PubMed ID: 28768201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TFIIH interacts with the retinoic acid receptor gamma and phosphorylates its AF-1-activating domain through cdk7.
    Bastien J; Adam-Stitah S; Riedl T; Egly JM; Chambon P; Rochette-Egly C
    J Biol Chem; 2000 Jul; 275(29):21896-904. PubMed ID: 10748061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of CDK7 reveals high-confidence targets and new models for TFIIH function in transcription.
    Rimel JK; Poss ZC; Erickson B; Maas ZL; Ebmeier CC; Johnson JL; Decker TM; Yaron TM; Bradley MJ; Hamman KB; Hu S; Malojcic G; Marineau JJ; White PW; Brault M; Tao L; DeRoy P; Clavette C; Nayak S; Damon LJ; Kaltheuner IH; Bunch H; Cantley LC; Geyer M; Iwasa J; Dowell RD; Bentley DL; Old WM; Taatjes DJ
    Genes Dev; 2020 Nov; 34(21-22):1452-1473. PubMed ID: 33060135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7.
    Chen D; Riedl T; Washbrook E; Pace PE; Coombes RC; Egly JM; Ali S
    Mol Cell; 2000 Jul; 6(1):127-37. PubMed ID: 10949034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase 7 controls mRNA synthesis by affecting stability of preinitiation complexes, leading to altered gene expression, cell cycle progression, and survival of tumor cells.
    Kelso TW; Baumgart K; Eickhoff J; Albert T; Antrecht C; Lemcke S; Klebl B; Meisterernst M
    Mol Cell Biol; 2014 Oct; 34(19):3675-88. PubMed ID: 25047832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro.
    Lu H; Fisher RP; Bailey P; Levine AJ
    Mol Cell Biol; 1997 Oct; 17(10):5923-34. PubMed ID: 9315650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo potentiation of human oestrogen receptor alpha by Cdk7-mediated phosphorylation.
    Ito S; Takeyama K; Yamamoto A; Sawatsubashi S; Shirode Y; Kouzmenko A; Tabata T; Kato S
    Genes Cells; 2004 Oct; 9(10):983-92. PubMed ID: 15461668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy.
    Holcakova J; Muller P; Tomasec P; Hrstka R; Nekulova M; Krystof V; Strnad M; Wilkinson GW; Vojtesek B
    PLoS One; 2014; 9(2):e89228. PubMed ID: 24586613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference with ER-α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER-positive breast cancer cells.
    Węsierska-Gądek J; Gritsch D; Zulehner N; Komina O; Maurer M
    J Cell Biochem; 2011 Apr; 112(4):1103-17. PubMed ID: 21308739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.